Just Healthcare

Just Healthcare

Epilepsy Drug Offers Options for Obstructive Sleep Apnea Treatment

Sulthiame emerges as a promising non-invasive therapy for sleep apnea patients

Naveen Sankar S's avatar
Naveen Sankar S
Sep 24, 2024
∙ Paid
Share
A serene nighttime scene showing a person sleeping comfortably in bed, with soft moonlight coming through the window. Next to the bed, a pill bottle labeled 'Sulthiame' is on the bedside table, symbolizing the new treatment for obstructive sleep apnea. The setting conveys calmness and relief, with subtle medical elements like a breathing chart or soft lines suggesting improved airflow. The overall feel is positive and hopeful, highlighting the potential of this new medication in improving sleep health.

Topline: A recent study highlights the potential of sulthiame, a drug traditionally used for epilepsy, to significantly reduce symptoms of obstructive sleep apnea (OSA), offering a viable alternative to mechanical treatments like CPAP.

Study Details: The study, presented at the European Respiratory Society Congress 2024, explored the effectiveness of sul…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture